Premier Clinical Research_Site number 130 — Spokane, Washington

Premier Clinical Research_Site number 130 is a clinical research site located in Spokane, Washington, United States 99202.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Premier Clinical Research_Site number 130 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Premier Clinical Research_Site number 130?

Premier Clinical Research_Site number 130 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Premier Clinical Research_Site number 130 conducted?

Premier Clinical Research_Site number 130 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Premier Clinical Research_Site number 130 accredited by Crixeo Health?

Premier Clinical Research_Site number 130 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Premier Clinical Research_Site number 130?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.